Akcea Therapeutics Inc (AKCA) Stock Analyst Ratings
NASDAQ:AKCA - Nasdaq -
ChartMill assigns a Buy % Consensus number of 60% to AKCA. The Buy consensus is the weighted average rating of the current analysts ratings.
AKCA was analyzed by 3 analysts. The buy percentage consensus is at 60. So analysts seem to be rather neutral about AKCA.
In the last month the buy percentage fell by 10 points. So the trust of analysts is decreasing.
Only 3 analysts analyzed AKCA. So this is just the average opinion of a couple of analysts.